SureTrader
Home > Boards > US Listed > Biotechs > Aurinia Pharmaceuticals Inc (AUPH)

Aurinia Falls On Misinterpreted 'Downgrade'

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
somerssalt Member Profile
 
Followed By 1
Posts 19
Boards Moderated 0
Alias Born 05/03/17
160x600 placeholder
Aurinia Pharmaceuticals Launches New Lupus Nephritis Disease Awareness Program Business Wire - 2/14/2018 8:00:00 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/13/2018 9:38:11 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 2/9/2018 12:07:07 PM
Aurinia Enhances Commercial and Business Development Expertise with the Appointment of Joseph P. Hagan to its Board of Direct... Business Wire - 2/8/2018 8:00:00 AM
Aurinia to Present at Leerink Partners 7th Annual Global Healthcare Conference Business Wire - 2/6/2018 8:00:00 AM
Appointment of Agent for Service of Process and Undertaking (f-x) Edgar (US Regulatory) - 1/4/2018 5:13:27 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 1/4/2018 4:46:59 PM
Aurinia Pharmaceuticals Files New Preliminary Base Shelf Prospectus to Replace Expired Base Shelf Prospectus Business Wire - 1/4/2018 4:37:00 PM
Registration Statement for Securities of Certain Canadian Issuers Under the Securities Act of 1933 (f-10) Edgar (US Regulatory) - 1/4/2018 4:32:10 PM
Aurinia Pharmaceuticals Added to the NASDAQ Biotech Index Business Wire - 12/11/2017 4:02:00 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 11/14/2017 4:36:44 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 11/14/2017 4:05:25 PM
Aurinia Reports Third Quarter 2017 Financial Results and Provides Operational Highlights Business Wire - 11/14/2017 4:00:00 PM
Aurinia Pharmaceuticals to Release Third Quarter 2017 Financial Results on November 14, 2017 Business Wire - 11/6/2017 4:05:00 PM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 10/23/2017 5:11:55 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/20/2017 8:02:06 AM
Aurinia to Expand Renal Franchise with Novel Indications and Launches Development Program for Treatment of Dry Eye Syndrome Business Wire - 10/20/2017 8:00:00 AM
Aurinia Receives National Corporate Visionary Award from the Lupus Foundation of America Business Wire - 10/12/2017 7:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 9/19/2017 4:10:24 PM
Aurinia to Host R&D Day and Webcast on October 20th in New York, NY Business Wire - 9/19/2017 4:01:00 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 9/5/2017 4:07:10 PM
Aurinia to Webcast at Upcoming Investor Conferences Business Wire - 9/5/2017 1:05:00 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 8/10/2017 4:37:23 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 8/10/2017 4:31:45 PM
Aurinia Reports Second Quarter 2017 Financial Results, and Provides Operational Highlights Business Wire - 8/10/2017 4:30:00 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist